NCT07276256

Brief Summary

This study looks at people who come to the hospital with acute coronary syndrome, a serious heart condition. When these patients first arrive, doctors take routine blood tests. The investigators use these test results to calculate a value called the leukoglycemic index (LGI), which combines white blood cell count and blood sugar level. The investigators also use a heart imaging score called the SYNTAX score to see how complex their coronary artery disease is. Patients are divided into two groups based on their SYNTAX scores: one group with lower scores (22 or less), and one with higher scores (above 22). The investigators compare their health data to see if LGI is linked to the severity of their heart disease. The investigators also check if LGI can help predict how complex the disease is. Information like age, family history, and chronic illnesses is collected from patient records and medical interviews.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
552

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 24, 2025

Completed
27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 21, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 21, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 28, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 11, 2025

Completed
3 months until next milestone

Results Posted

Study results publicly available

February 25, 2026

Completed
Last Updated

February 25, 2026

Status Verified

December 1, 2025

Enrollment Period

27 days

First QC Date

November 28, 2025

Results QC Date

December 15, 2025

Last Update Submit

February 7, 2026

Conditions

Keywords

Acute coronary syndromeCoronary artery diseaseinflammationrisk stratificationSYNTAX scoreleukoglycemic index

Outcome Measures

Primary Outcomes (1)

  • Leukoglycemic Index (LGI)

    The LGI is calculated as the product of blood glucose concentration (mg/dL) and leukocyte count (cells/mm³). This composite measure provides a single numerical value that reflects both metabolic status (via blood glucose) and hematological status (via white blood cell count). At baseline, LGI serves as an integrated indicator of participants' metabolic and immune activity. It is simple to compute and offers a practical way to capture two fundamental aspects of health in one measure. Higher values are considered worse outcomes because they reflect an increased metabolic and inflammatory burden

    First day

Study Arms (2)

SYNTAX score =<22

Other: leukoglycemic index calculation

SYNTAX score >22

Other: leukoglycemic index calculation

Interventions

leukoglycemic index calculation

SYNTAX score =<22SYNTAX score >22

Eligibility Criteria

Age18 Years - 88 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with acute coronary syndrome

You may qualify if:

  • Adult patients aged 18 years and older
  • Patients who underwent coronary angiography due to acute coronary syndrome

You may not qualify if:

  • Patients with diabetes mellitus (Diagnosis based on current use of oral antidiabetic or insulin therapy and/or fasting glucose level ≥126 mg/dL and HbA1c ≥6.5%)
  • Patients with atrial fibrillation, history of pacemaker implantation, asthma, pulmonary hypertension, pregnancy, anemia, malignancy, rheumatoid arthritis, or peripheral artery disease
  • Obese individuals (defined as body mass index \[BMI\] \>30 kg/m²)
  • Patients whose medical records could not be accessed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kırıkkale university

Kırıkkale, Kırıkkale, 71000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Acute Coronary SyndromeCoronary Artery DiseaseInflammation

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesCoronary DiseaseArteriosclerosisArterial Occlusive DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Limitations and Caveats

There was no limitation about the study

Results Point of Contact

Title
Rukiye GONEN OZDEMIR
Organization
Kırıkkale University, Faculty of Medicine, Department of Cardiology

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical doctor

Study Record Dates

First Submitted

November 28, 2025

First Posted

December 11, 2025

Study Start

September 24, 2025

Primary Completion

October 21, 2025

Study Completion

October 21, 2025

Last Updated

February 25, 2026

Results First Posted

February 25, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations